Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -114.79% is 150% below its 5-year average of -45.91%, near the low end of its 5-year range (-114.79%–-6.96%).
70.83% below its 12-month average of -67.19%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -35.89%.
RETURN ON ASSETS (ROA)
-114.79%
RETURN ON ASSETS (ROA) AVG TTM
-67.19%
RETURN ON ASSETS (ROA) AVG 3Y
-63.94%
RETURN ON ASSETS (ROA) AVG 5Y
-45.91%
RETURN ON ASSETS (ROA) AVG 10Y
-25.65%
RETURN ON ASSETS (ROA) AVG 15Y
-0.73%
RETURN ON ASSETS (ROA) AVG 20Y
-14.98%
CURRENT VS TTM AVG
-70.83%
CURRENT VS 3Y AVG
-79.51%
CURRENT VS 5Y AVG
-150.01%
CURRENT VS 10Y AVG
-347.52%
CURRENT VS 15Y AVG
-15608.11%
CURRENT VS 20Y AVG
-666.47%
SECTOR MEDIAN · HEALTHCARE
-29.15%
median of 609 covered companies
CURRENT VS SECTOR MEDIAN
-293.79%
vs the sector median at left
CAMP4 Therapeutics Corporation
Market Cap
$242.85M
Return on Assets (ROA)
-114.79%
TTM Avg
-67.19%
3Y Avg
-63.94%
5Y Avg
-45.91%
Market Cap
$235.77M
Return on Assets (ROA)
-8.48%
TTM Avg
-16.43%
3Y Avg
-20.20%
5Y Avg
-32.31%
Market Cap
$237.27M
Return on Assets (ROA)
-8.99%
TTM Avg
-7.90%
3Y Avg
-14.69%
5Y Avg
-13.78%
Market Cap
$237.74M
Return on Assets (ROA)
-187.80%
TTM Avg
-213.40%
3Y Avg
-188.65%
5Y Avg
-151.14%
Market Cap
$238.61M
Return on Assets (ROA)
-23.88%
TTM Avg
-71.64%
3Y Avg
-51.89%
5Y Avg
-47.09%
Market Cap
$232.73M
Return on Assets (ROA)
-23.80%
TTM Avg
-23.59%
3Y Avg
-108.30%
5Y Avg
-108.30%
Market Cap
$241.61M
Return on Assets (ROA)
-49.04%
TTM Avg
-75.08%
3Y Avg
-74.95%
5Y Avg
-71.96%
Market Cap
$243.64M
Return on Assets (ROA)
-244.25%
TTM Avg
-369.36%
3Y Avg
-230.97%
5Y Avg
-157.86%
Market Cap
$243.81M
Return on Assets (ROA)
N/A
TTM Avg
-14.72%
3Y Avg
-16.00%
5Y Avg
-18.82%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $242.85M | -114.79% | -67.19% | -63.94% | -45.91% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.77M | -8.48% | -16.43% | -20.20% | -32.31% |
| High Tide Inc. (HITI)vs › | $237.27M | -8.99% | -7.90% | -14.69% | -13.78% |
| Galectin Therapeutics Inc. (GALT)vs › | $237.74M | -187.80% | -213.40% | -188.65% | -151.14% |
| InflaRx N.V. (IFRX)vs › | $238.61M | -23.88% | -71.64% | -51.89% | -47.09% |
| BioAge Labs Inc. (BIOA)vs › | $232.73M | -23.80% | -23.59% | -108.30% | -108.30% |
| Invivyd, Inc. (IVVD)vs › | $241.61M | -49.04% | -75.08% | -74.95% | -71.96% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.64M | -244.25% | -369.36% | -230.97% | -157.86% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | N/A | -14.72% | -16.00% | -18.82% |
| MacroGenics, Inc. (MGNX)vs › | $229.14M | -4.22% | -27.32% | -24.76% | -32.27% |
ROA
-114.8%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -68.25% |
| 2024-12-31 | -66.14% |
| 2023-12-31 | -89.71% |
| 2023-02-28 | -31.68% |
| 2022-02-28 | -6.96% |
| 2021-02-28 | -12.74% |
| 2020-02-29 | -15.89% |
| 2019-02-28 | 3.05% |
| 2018-02-28 | 3.51% |
| 2017-02-28 | -1.75% |
| 2016-02-29 | 4.41% |
| 2015-02-28 | 8.15% |
| 2014-02-28 | 6.58% |
| 2013-02-28 | 29.60% |
| 2012-02-28 | 10.14% |
| 2011-02-28 | -5.92% |
| 2010-02-28 | -19.05% |
| 2009-02-28 | -71.31% |
| 2008-03-01 | -58.83% |
| 2007-03-03 | -13.58% |
| 2006-02-28 | 7.13% |
| 2005-02-28 | 4.10% |
| 2004-02-28 | 5.85% |
| 2003-03-01 | 5.76% |
| 2002-02-28 | 7.87% |
| 2001-03-03 | 10.46% |
| 2000-02-26 | -2.51% |
| 1999-02-27 | -5.49% |
| 1998-02-28 | -9.71% |
| 1997-03-01 | 2.03% |
